Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents)

NACompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DEVICE

AKL-T01

"AKL-T01 multitasking digital treatment. AKL-T01 multitasking treatment employs perceptual discrimination attention/memory task as well as a continuous motor driving task."

Trial Locations (14)

21229

MTP Psychiatry, Baltimore

27606

MindPath Care Centers, Raleigh

32751

Accel Research Sites, Maitland

45206

Cincinnati Children's Hospital, Cincinnati

45409

Dayton Clinical Research, Dayton

63304

Midwest Research Group, Saint Charles

68516

Lincoln Pediatric Group, Lincoln

68526

Alivation Research, Lincoln

73106

IPS Research, Oklahoma City

77089

Southeast Houston Research, Inc., Houston

85254

Melmed Center, Scottsdale

87109

Albuquerque Neuroscience, Inc., Albuquerque

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

92121

Cortica, Inc., San Diego

All Listed Sponsors
lead

Akili Interactive Labs, Inc.

INDUSTRY